Krka expects bribery investigation results by end of month

Novo Mesto, 17 January - The Slovenian pharma Krka said on Friday that its internal investigation into alleged bribery activities in the company's Romanian subsidiary was expected to be completed by the end of January. If any irregularities affecting Krka's business performance are indeed uncovered, the drug maker would publicly report on them.